| T2D | Type 2 Diabetes |
| IDF | International Diabetes Federation |
| HbA1c | Glycated Hemoglobin |
| PCr | Phosphocreatine |
| CK | Creatine Kinase |
| CRTR | Creatine Transporter |
| ROS | Reactive Oxygen Species |
| AMPK | AMP-Activated Protein Kinase |
| PGC-1α | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha |
| NF-κB | Nuclear Factor Kappa B |
| p38 MAPK | P38 Mitogen-Activated Protein Kinase |
| TNF-α | Tumor Necrosis Factor Alpha |
| IL-1β | Interleukin-1 Beta |
| STAT1/3 | Signal Transducer And Activator Of Transcription 1/3 |
| IGF-1 | Insulin-Like Growth Factor 1 |
| GH | Growth Hormone |
| mTORC1 | Mechanistic Target Of Rapamycin Complex 1 |
| GLUT4 | Glucose Transporter Type 4 |
| Akt/PKB | Protein Kinase B |
| Rac1 | Ras-Related C3 Botulinum Toxin Substrate 1 |
| CaMK | Calcium/Calmodulin-Dependent Protein Kinase |
| IRS | Insulin Receptor Substrate |
| WHO | World Health Organization |
| OGTT | Oral Glucose Tolerance Test |
| HOMA-IR | Homeostatic Model Assessment Of Insulin Resistance |
| CrM | Creatine Monohydrate |
| ISSN | International Society Of Sports Nutrition |
| Cmax | Maximum Plasma Concentration |
| Tmax | Time To Reach Maximum Plasma Concentration |
| AUC | Area Under The Curve |
| CEE | Creatine Ethyl Ester |
| DDInter | Drug–Drug Interaction Database |